EP2394665 - Cell-penetrating peptides and uses thereof [Right-click to bookmark this link] | |||
Former [2011/50] | Cell-penetrating peptides and uses therof | ||
[2012/07] | Status | The application is deemed to be withdrawn Status updated on 09.11.2012 Database last updated on 02.11.2024 | Most recent event Tooltip | 09.11.2012 | Application deemed to be withdrawn | published on 12.12.2012 [2012/50] | Applicant(s) | For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | [2011/50] | Inventor(s) | 01 /
Brinkmann, Ulrich Roche Diagnostics GmbH Nonnenwald 2 82377, Penzberg / DE | 02 /
Haas, Alexander Roche Diagnostics GmbH Nonnenwald 2 82377, Penzberg / DE | [2011/50] | Representative(s) | Dilg, Haeusler, Schindelmann Patentanwaltsgesellschaft mbH Leonrodstraße 58 80636 München / DE | [N/P] |
Former [2011/50] | Dilg, Haeusler, Schindelmann Patentanwaltsgesellschaft mbH Leonrodstrasse 58 80636 München / DE | Application number, filing date | 10165793.0 | 14.06.2010 | [2011/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2394665 | Date: | 14.12.2011 | Language: | EN | [2011/50] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 16.03.2011 | Classification | IPC: | A61K47/48, C07K14/00 | [2011/50] | CPC: |
C07K14/475 (EP);
C07K14/47 (EP);
C07K14/4723 (EP);
C12N15/87 (EP);
C07K2319/10 (EP);
C12N15/111 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/50] | Extension states | BA | Not yet paid | ME | Not yet paid | RS | Not yet paid | Title | German: | Zellenpenetrierende Peptide und Verwendungen davon | [2011/50] | English: | Cell-penetrating peptides and uses thereof | [2012/07] | French: | Peptides pénétrant dans la cellule et leurs utilisations | [2011/50] |
Former [2011/50] | Cell-penetrating peptides and uses therof | Examination procedure | 15.06.2012 | Application deemed to be withdrawn, date of legal effect [2012/50] | 23.07.2012 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2012/50] | Fees paid | Penalty fee | Additional fee for renewal fee | 30.06.2012 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US7067473 (MASURE STEFAN LEO JOZEF [BE]) [X] 1-19 * sequence 20 *; | [A]WO9708196 (UNIV WASHINGTON [US], et al) [A] 1-19 * figure 17; sequence 109 *; | [A]WO2007069068 (DIATOS [FR], et al) [A] 1-19 * the whole document *; | [A]US7173007 (ZAIOU MOHAMED [FR], et al) [A] 1-19 * claim 9 *; | [X] - HEITZ FREDERIC ET AL, "Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics", BRITISH JOURNAL OF PHARMACOLOGY MAY 2009,, (20090320), vol. 157, no. 2, pages 195 - 206, XP002566600 [X] 1-3 * table 1 * DOI: http://dx.doi.org/10.1111/J.1476-5381.2008.00057.X | [X] - FONSECA S B ET AL, "Recent advances in the use of cell-penetrating peptides for medical and biological applications", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL LNKD- DOI:10.1016/J.ADDR.2009.06.001, vol. 61, no. 11, ISSN 0169-409X, (20090930), pages 953 - 964, (20090616), XP026666155 [X] 1-19 * table 1 * DOI: http://dx.doi.org/10.1016/j.addr.2009.06.001 | [XD] - GREEN M ET AL, "Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein", CELL, CELL PRESS, CAMBRIDGE, NA, US LNKD- DOI:10.1016/0092-8674(88)90262-0, vol. 55, no. 6, ISSN 0092-8674, (19881223), pages 1179 - 1188, (19881223), XP024244889 [XD] 1-19 * abstract * * page 1184, column l * DOI: http://dx.doi.org/10.1016/0092-8674(88)90262-0 | [A] - "Human cathelin-like protein, CAP18/LL-37 protein fragment (aa: 132-170).", Geneseq, (20070531), Database accession no. AEV74707, URL: EBI, XP002604128 [A] 1-19 * the whole document * | by applicant | - ELBASHIR, S.M. ET AL., NATURE, (2001), vol. 411, pages 494 - 498 | - DE FOUGEROLLES, A. ET AL., NAT. REV. DRUG DISCOV., (2007), vol. 6, pages 443 - 453 | - SCHROEDER; A. ET AL., J. INTERN. MED., (2010), vol. 267, pages 9 - 21 | - LIU, Y.P; BERKHOUT, B., CURR. TOP. MED. CHEM., (2009), vol. 9, pages 1130 - 1143 | - HOWARD, K.A., ADV. DRUG DELIV. REV., (2009), vol. 61, pages 710 - 720 | - FONSECA, S.B ET AL., ADV. DRUG DELIV. REV., (2009), vol. 61, pages 953 - 964 | - HEITZ, F. ET AL., BR. J. PHARMACOL., (2009), vol. 157, pages 195 - 206 | - GREEN; M.; LOEWENSTEIN, P.M., CELL, (1988), vol. 55, pages 1179 - 1188 | - JOLIOT; A. ET AL., PROC. NATL. ACAD. SCI. USA, (1991), vol. 88, pages 1864 - 1868 | - DEROSSI, D. ET AL., J. BIOL. CHEM., (1994), vol. 269, pages 10444 - 10450 | - VIVES, E. ET AL., J. BIOL. CHEM., (1997), vol. 272, pages 16010 - 16017 | - OEHLKE, J. ET AL., BIOCHIM. BIOPHYS. ACTA, (1998), vol. 1414, pages 127 - 139 | - FISCHER, R. ET AL., J. BIOL. CHEM., (2004), vol. 279, pages 12625 - 12635 | - ROTHBARD, J.B. ET AL., ADV. DRUG DELIV. REV., (2005), vol. 57, pages 495 - 504 | - SOOMETS, U. ET AL., BIOCHIM. BIOPHYS. ACTA, (2000), vol. 1467, pages 165 - 176 | - ALTSCHUL, S.F. ET AL., J. MOL. BIOL., (1990), vol. 215, pages 403 - 410 | - LIPMAN, D.J.; PEARSON, W.R., SCIENCE, (1985), vol. 227, pages 1435 - 1441 | - SMITH, T.F.; WATERMAN, M.S., J. MOL. BIOL., (1981), vol. 147, pages 195 - 197 | - HENIKOFF, S.; HENIKOFF, J.G., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 10915 - 10919 | - HIGGINS, D. ET AL., NUCL. ACIDS RES., (1994), vol. 2, pages 4673 - 4680 | - MICHALSKY, E. ET AL., PROTO ENG., (2003), vol. 56, pages 979 - 985 | - BARTEL, D.P., CELL, (2004), vol. 23, pages 281 - 292 | - HE, L.; HANNON, G.J., NAT. REV. GENET., (2004), vol. 5, pages 522 - 531 | - DORSETT, Y.; TUSCHL. T, NAT. REV. DRUG DISC., (2004), vol. 3, pages 318 - 329 | - RANA, T.M., NAT. REV. MOL. CELL BIOL., (2007), vol. 8, pages 23 - 36 | - SIOLAS, D. ET AL., NAT. BIOTECHNOL., (2004), vol. 23, pages 227 - 231 | - OROM, U.A. ET AL., GENE, (2006), vol. 372, pages 137 - 141 | - KRUTZFELDT, J. ET AL., NATURE, (2005), vol. 438, pages 685 - 689 | - EBERT, M.S. ET AL., NAT. METHODS, (2007), vol. 4, pages 721 - 726 | - FRANKEL, A.D.; PABO, C.O., CELL, (1988), vol. 55, pages 1189 - 1193 | - WENDER, P.A. ET AL., PROC. NATL. ACAD. SCI. USA, (2000), vol. 97, pages 13003 - 13008 | - FUTAKI, S. ET AL., J. BIOL. CHEM., (2001), vol. 276, pages 5836 - 5840 | - LINS, L. ET AL., BIOCHIM. BIOPHYS. ACTA, (2008), vol. 1778, pages 1537 - 1544 | - ASHBURNER, M. ET AL., NAT. GENET., (2000), vol. 25, pages 25 - 39 | - DESHAYES, S. ET AL., BIOCHEMISTRY, (2004), vol. 43, pages 7698 - 7706 | - NIIDOME, T. ET AL., BIOCONJUG. CHEM., (1999), vol. 10, pages 773 - 780 | - YANG, Y.X. ET AL., ACTA PHARMACOL. SIN., (2004), vol. 25, pages 239 - 245 | - DEMANT, T. ET AL., J. LIPID RES., (1988), vol. 29, pages 1603 - 1611 | - NIJINK, A.; HANCOCK, R.E., CURR. OPIN. HEMATOL., (2009), vol. 16, pages 41 - 47 | - MULERO, J.J. ET AL., IMMUNOGENETICS, (2002), vol. 54, pages 293 - 300 | - TAKESHIMA, K. ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 1310 - 1315 | - ARRIGHI, R.B. ET AL., ANTIMICROB. AGENTS CHEMOTHER., (2008), vol. 52, pages 3414 - 3417 | - IGNATOVICH, I.A. ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 42625 - 42636 | - KIM, W.J. ET AL., MOL. THER., (2006), vol. 14, pages 343 - 350 | - NASCIMENTO, F.D. ET AL., J. BIOL. CHEM., (2007), vol. 282, pages 21349 - 21360 | - SONG, E. ET AL., NAT. BIOTECHNOL., (2005), vol. 23, pages 709 - 717 | - PLANK, C. ET AL., J. BIOL. CHEM., (1994), vol. 269, pages 12918 - 12924 | - LIN, Y.Z. ET AL., J. BIOL. CHEM., (1995), vol. 270, pages 14255 - 14258 | - DUCHARDT, F. ET AL., TRAFFIC, (2007), vol. 8, pages 848 - 866 | - PANARETOU, B. ET AL., MOL. CELL, (2002), vol. 10, pages 1307 - 1318 | - MAZIERES, J. ET AL., ONCOGENE, (2005), vol. 24, pages 5396 - 5400 | - BINGLE, C.D.; CRAVEN, C.J., TRENDS IMMUNOL., (2004), vol. 25, pages 53 - 55 | - KOTZBAUER, P.T. ET AL., NATURE, (1996), vol. 384, pages 467 - 470 | - LAW, M. ET AL., BIOTECHNOL. PROG., (2008), vol. 24, pages 957 - 963 | - WOLFERT, M.A.; SEYMOUR, L.W., GENE THER., (1996), vol. 3, pages 269 - 273 | - BLANGY, A. ET AL., CELL, (1995), vol. 83, pages 1159 - 1169 | - ROSADO, C.J. ET AL., CELL. MICROBIOL., (2008), vol. 10, pages 1765 - 1774 | - PALM-APERGI, C. ET AL., FASEB J., (2009), vol. 23, pages 214 - 223 | - CROMBEZ, L. ET AL., BIOCHEM. SOC. TRANS., (2007), vol. 35, pages 44 - 46 | - JAFARI, M; CHEN, P., CURR. TOP. MED. CHEM., (2009), vol. 9, pages 1088 - 1097 | - EIGENBROT, C.; GERBER, N, NAT. STRUCT. BIOL., (1997), vol. 4, pages 435 - 438 | - SIMEONI, F. ET AL., NUCLEIC ACIDS RES., (2003), vol. 31, pages 2717 - 2724 | - RICHARD, J.P. ET AL., J. BIOL. CHEM., (2005), vol. 280, pages 15300 - 15306 | - ABES, R. ET AL., BIOCHEM. SOC. TRANS., (2007), vol. 35, pages 775 - 779 | - KUMAR, P. ET AL., NATURE, (2007), vol. 448, pages 39 - 43 | - MUELLER, J. ET AL., BIOCONJUG. CHEM., (2008), vol. 19, pages 2363 - 2374 | - SUGITA, T. ET AL., BR. J. PHARMACOL., (2008), vol. 153, pages 1143 - 1152 | - MATHUPALA, S.P., EXPERT OPIN. THER. PAT., (2009), vol. 19, pages 137 - 140 | - SARIOLA, H.; SAARMA, M., J. CELL SCI., (2003), vol. 116, pages 3855 - 3862 | - WEKSLER, B.B. ET AL., FASEB J., (2005), vol. 19, pages 1872 - 1874 | - POLLER, B. ET AL., J. NEUROCHEM., (2008), vol. 107, pages 1358 - 1363 |